wal hist 12 hour relief
Dosage form: tablet
Ingredients: CLEMASTINE FUMARATE 1.34mg
Labeler: Walgreen Company
NDC code: 0363-0707
Medically reviewed by Drugs.com. Last updated on Nov 23, 2023.
Active ingredient (in each tablet)
Clemastine fumarate, USP 1.34 mg (equivalent to 1 mg clemastine)
Purpose
Antihistamine
Uses
temporarily reduces these symptoms of the common cold, hay fever, and other respiratory allergies:
- •
- runny nose
- •
- itchy, watery eyes
- •
- sneezing
- •
- itching of the nose or throat
Warnings
Ask a doctor before use if you have
- •
- a breathing problem such as emphysema or chronic bronchitis
- •
- glaucoma
- •
- trouble urinating due to an enlargement of the prostate gland
Ask a doctor or pharmacist before use if you are
taking sedatives or tranquilizers
When using this product
- •
- avoid alcoholic drinks
- •
- drowsiness may occur
- •
- alcohol, sedatives, and tranquilizers may increase drowsiness
- •
- be careful when driving a motor vehicle or operating machinery
- •
- excitability may occur, especially in children
If pregnant or breast-feeding,
ask a health professional before use.
Keep out of reach of children.
In case of overdose, get medical help or contact a Poison Control Center right away.
Directions
- •
- adults and children 12 years of age and over: take 1 tablet every 12 hours; not more than 2 tablets in 24 hours unless directed by a doctor
- •
- children under 12 years of age: consult a doctor
Other information
- •
- sodium free
- •
- store at 15°-30°C (59°-86°F)
Inactive ingredients
colloidal silicon dioxide, corn starch, lactose monohydrate, povidone, pregelatinized starch, stearic acid
Questions or comments?
1-800-719-9260
WAL HIST
12 HOUR RELIEF
clemastine fumarate tablet |
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
Labeler - Walgreen Company (008965063) |
Revised: 12/2019
Document Id: 6fecdbc5-7957-4ae3-9e3b-12566b4c8c76
Set id: a049607d-f5b1-4cdd-ada0-71003dd843ab
Version: 2
Effective Time: 20191203
Walgreen Company
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.